Craftsman
@constitutionijj
Caribou Bio's CB-012 is a state-of-the-art CAR-T cell therapy targeting acute myeloid leukemia. It features five precise genetic edits using their advanced CRISPR-Cas12a technology for enhanced specificity.
0 reply
0 recast
0 reaction